Skip to main content
SpringerLink
Log in

GLP-1-Analoga bei nichtalkoholischer Steatohepatitis

GLP-1-analogs in the treatment of steatohepatitis

  • Journal Club
  • Published:
Der Diabetologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Charlton MR, Burns JM, Pedersen RA et al (2011) Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 141:1249–1253

    Article  PubMed  Google Scholar 

  2. Armstrong MJ, Adams LA, Canbay A et al (2014) Extra-hepatic complications of nonalcoholic fatty liver disease. Hepatology 59:1174–1197

    Article  CAS  PubMed  Google Scholar 

  3. Ding X, Saxena NK, Lin S et al (2006) Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice. Hepatology 43:173–181

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Gupta NA, Mells J, Dunham RM et al (2010) Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway. Hepatology 51:1584–1592

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ben-Shlomo S, Zvibel I, Shnell M et al (2011) Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase. J Hepatol 54:1214–1223

    Article  CAS  PubMed  Google Scholar 

  6. Gaborit B, Darmon P, Ancel P, Dutour A (2016) Liraglutide for patients with non-alcoholic steatohepatitis. Lancet 387:2378–2379

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department für Innere Medizin, Neurologie und Dermatologie Klinik und Poliklinik für Endokrinologie und Nephrologie, Universitätsklinikum Leipzig, Liebigstr. 20, 04103, Leipzig, Deutschland

    H. Schlögl

Authors
  1. H. Schlögl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Schlögl.

Ethics declarations

Interessenkonflikt

H. Schlögl gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schlögl, H. GLP-1-Analoga bei nichtalkoholischer Steatohepatitis. Diabetologe 12, 432–433 (2016). https://doi.org/10.1007/s11428-016-0132-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-016-0132-3

Search

Navigation